Structure

Physi-Chem Properties

Molecular Weight:  290.12
Volume:  296.312
LogP:  2.648
LogD:  2.15
LogS:  -3.132
# Rotatable Bonds:  4
TPSA:  79.9
# H-Bond Aceptor:  5
# H-Bond Donor:  2
# Rings:  2
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.846
Synthetic Accessibility Score:  3.448
Fsp3:  0.312
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.783
MDCK Permeability:  1.3055892850388773e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.038
Human Intestinal Absorption (HIA):  0.047
20% Bioavailability (F20%):  0.525
30% Bioavailability (F30%):  0.274

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.039
Plasma Protein Binding (PPB):  80.6231460571289%
Volume Distribution (VD):  1.339
Pgp-substrate:  20.14339828491211%

ADMET: Metabolism

CYP1A2-inhibitor:  0.666
CYP1A2-substrate:  0.955
CYP2C19-inhibitor:  0.068
CYP2C19-substrate:  0.814
CYP2C9-inhibitor:  0.092
CYP2C9-substrate:  0.869
CYP2D6-inhibitor:  0.041
CYP2D6-substrate:  0.597
CYP3A4-inhibitor:  0.049
CYP3A4-substrate:  0.463

ADMET: Excretion

Clearance (CL):  8.619
Half-life (T1/2):  0.529

ADMET: Toxicity

hERG Blockers:  0.004
Human Hepatotoxicity (H-HT):  0.106
Drug-inuced Liver Injury (DILI):  0.746
AMES Toxicity:  0.362
Rat Oral Acute Toxicity:  0.156
Maximum Recommended Daily Dose:  0.256
Skin Sensitization:  0.219
Carcinogencity:  0.162
Eye Corrosion:  0.003
Eye Irritation:  0.112
Respiratory Toxicity:  0.392

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC139554

Natural Product ID:  NPC139554
Common Name*:   Perforamone B
IUPAC Name:   5-hydroxy-8-(1-hydroxy-3-methylbut-3-enyl)-7-methoxy-2-methylchromen-4-one
Synonyms:   Perforamone B
Standard InCHIKey:  NECCMSLPKRWTRS-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C16H18O5/c1-8(2)5-10(17)15-13(20-4)7-12(19)14-11(18)6-9(3)21-16(14)15/h6-7,10,17,19H,1,5H2,2-4H3
SMILES:  C=C(C)CC(c1c(cc(c2c(=O)cc(C)oc12)O)OC)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2204371
PubChem CID:   11608981
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0000144] Chromones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21362 Harrisonia perforata Species Rutaceae Eukaryota n.a. root n.a. PMID[16394547]
NPO21362 Harrisonia perforata Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[23688954]
NPO21362 Harrisonia perforata Species Rutaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO21362 Harrisonia perforata Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO21362 Harrisonia perforata Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO21362 Harrisonia perforata Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT115 Organism Mycobacterium tuberculosis H37Ra Mycobacterium tuberculosis H37Ra MIC = 25.0 ug.mL-1 PMID[497257]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC139554 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9774 High Similarity NPC174999
0.9704 High Similarity NPC23257
0.9699 High Similarity NPC60667
0.9638 High Similarity NPC224714
0.9632 High Similarity NPC471587
0.963 High Similarity NPC131130
0.9627 High Similarity NPC156910
0.9627 High Similarity NPC470397
0.9624 High Similarity NPC125920
0.9562 High Similarity NPC258630
0.9562 High Similarity NPC17170
0.9562 High Similarity NPC96408
0.9562 High Similarity NPC156190
0.9562 High Similarity NPC279650
0.9562 High Similarity NPC166689
0.9559 High Similarity NPC471697
0.9549 High Similarity NPC223457
0.9549 High Similarity NPC108113
0.9549 High Similarity NPC93756
0.9496 High Similarity NPC470890
0.9496 High Similarity NPC319752
0.9493 High Similarity NPC78
0.9493 High Similarity NPC194432
0.9493 High Similarity NPC324436
0.9493 High Similarity NPC223500
0.9493 High Similarity NPC227579
0.9493 High Similarity NPC177354
0.9493 High Similarity NPC10937
0.9493 High Similarity NPC228504
0.9493 High Similarity NPC296917
0.9493 High Similarity NPC328164
0.9493 High Similarity NPC182852
0.9493 High Similarity NPC66515
0.9493 High Similarity NPC166482
0.9493 High Similarity NPC148757
0.9493 High Similarity NPC40833
0.9493 High Similarity NPC1089
0.9493 High Similarity NPC125855
0.9493 High Similarity NPC324134
0.9493 High Similarity NPC107572
0.9493 High Similarity NPC306829
0.9493 High Similarity NPC76372
0.9493 High Similarity NPC161506
0.9493 High Similarity NPC32739
0.9493 High Similarity NPC37496
0.9493 High Similarity NPC166934
0.9493 High Similarity NPC167624
0.9493 High Similarity NPC64915
0.9493 High Similarity NPC76338
0.9493 High Similarity NPC220998
0.9493 High Similarity NPC265040
0.9489 High Similarity NPC241100
0.9489 High Similarity NPC159275
0.9485 High Similarity NPC470669
0.9485 High Similarity NPC470668
0.9481 High Similarity NPC470398
0.9478 High Similarity NPC144027
0.9478 High Similarity NPC236974
0.9474 High Similarity NPC203817
0.9474 High Similarity NPC10971
0.9433 High Similarity NPC10097
0.9429 High Similarity NPC470458
0.9429 High Similarity NPC83357
0.9429 High Similarity NPC20488
0.9429 High Similarity NPC474161
0.9429 High Similarity NPC142405
0.9429 High Similarity NPC301276
0.9429 High Similarity NPC267375
0.9429 High Similarity NPC312973
0.9429 High Similarity NPC214774
0.9429 High Similarity NPC111786
0.9429 High Similarity NPC67805
0.9429 High Similarity NPC176229
0.9429 High Similarity NPC195621
0.9429 High Similarity NPC476088
0.9429 High Similarity NPC472629
0.9429 High Similarity NPC470647
0.9429 High Similarity NPC88964
0.9429 High Similarity NPC475052
0.9429 High Similarity NPC54577
0.9429 High Similarity NPC246948
0.9424 High Similarity NPC175504
0.9424 High Similarity NPC149026
0.9424 High Similarity NPC214166
0.9424 High Similarity NPC77794
0.9424 High Similarity NPC91560
0.9424 High Similarity NPC223812
0.9424 High Similarity NPC478086
0.9424 High Similarity NPC185276
0.9424 High Similarity NPC316816
0.9424 High Similarity NPC75049
0.9424 High Similarity NPC143896
0.9424 High Similarity NPC310130
0.9424 High Similarity NPC107177
0.9424 High Similarity NPC169591
0.9424 High Similarity NPC125894
0.9424 High Similarity NPC68104
0.9424 High Similarity NPC150408
0.9424 High Similarity NPC81697
0.9424 High Similarity NPC164980
0.9424 High Similarity NPC85162
0.9424 High Similarity NPC221432
0.9424 High Similarity NPC257097
0.9424 High Similarity NPC39329
0.9424 High Similarity NPC278249
0.942 High Similarity NPC213322
0.942 High Similarity NPC110038
0.942 High Similarity NPC4743
0.942 High Similarity NPC282300
0.942 High Similarity NPC110969
0.942 High Similarity NPC312391
0.942 High Similarity NPC248372
0.942 High Similarity NPC324386
0.9416 High Similarity NPC303633
0.9416 High Similarity NPC217186
0.9416 High Similarity NPC140890
0.9416 High Similarity NPC18260
0.9416 High Similarity NPC37206
0.9416 High Similarity NPC220062
0.9416 High Similarity NPC96565
0.9416 High Similarity NPC53181
0.9416 High Similarity NPC78913
0.9416 High Similarity NPC470211
0.9416 High Similarity NPC55018
0.9416 High Similarity NPC216978
0.9416 High Similarity NPC301217
0.9407 High Similarity NPC101752
0.9407 High Similarity NPC84699
0.9398 High Similarity NPC475589
0.9398 High Similarity NPC31872
0.9398 High Similarity NPC473584
0.9366 High Similarity NPC307052
0.9366 High Similarity NPC139966
0.9366 High Similarity NPC5173
0.9362 High Similarity NPC470670
0.9362 High Similarity NPC85773
0.9362 High Similarity NPC110303
0.9362 High Similarity NPC472627
0.9362 High Similarity NPC296998
0.9362 High Similarity NPC473133
0.9362 High Similarity NPC202494
0.9362 High Similarity NPC283234
0.9362 High Similarity NPC91902
0.9362 High Similarity NPC47388
0.9362 High Similarity NPC473077
0.9362 High Similarity NPC23728
0.9357 High Similarity NPC473013
0.9357 High Similarity NPC297788
0.9357 High Similarity NPC87486
0.9357 High Similarity NPC209040
0.9357 High Similarity NPC131579
0.9357 High Similarity NPC197252
0.9357 High Similarity NPC473014
0.9357 High Similarity NPC235217
0.9357 High Similarity NPC124780
0.9357 High Similarity NPC131568
0.9357 High Similarity NPC236766
0.9357 High Similarity NPC473015
0.9353 High Similarity NPC325346
0.9353 High Similarity NPC294432
0.9353 High Similarity NPC11561
0.9353 High Similarity NPC226636
0.9348 High Similarity NPC188243
0.9348 High Similarity NPC270883
0.9348 High Similarity NPC172986
0.9348 High Similarity NPC261227
0.9348 High Similarity NPC16455
0.9348 High Similarity NPC6407
0.9348 High Similarity NPC110228
0.9348 High Similarity NPC307990
0.9348 High Similarity NPC150522
0.9343 High Similarity NPC474504
0.9343 High Similarity NPC470399
0.9343 High Similarity NPC474487
0.9343 High Similarity NPC470672
0.9343 High Similarity NPC470671
0.9343 High Similarity NPC201395
0.9343 High Similarity NPC124269
0.9338 High Similarity NPC121243
0.9338 High Similarity NPC187826
0.9338 High Similarity NPC240147
0.9333 High Similarity NPC164136
0.9328 High Similarity NPC25937
0.9323 High Similarity NPC5515
0.9323 High Similarity NPC270369
0.9301 High Similarity NPC61258
0.9301 High Similarity NPC37348
0.9296 High Similarity NPC132592
0.9296 High Similarity NPC168085
0.9296 High Similarity NPC321623
0.9296 High Similarity NPC161191
0.9296 High Similarity NPC160821
0.9296 High Similarity NPC189087
0.9296 High Similarity NPC470460
0.9296 High Similarity NPC6511
0.9291 High Similarity NPC470133
0.9291 High Similarity NPC109183
0.9291 High Similarity NPC290133
0.9291 High Similarity NPC24136
0.9291 High Similarity NPC470132

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC139554 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.922 High Similarity NPD4378 Clinical (unspecified phase)
0.913 High Similarity NPD1550 Clinical (unspecified phase)
0.913 High Similarity NPD1552 Clinical (unspecified phase)
0.9065 High Similarity NPD1549 Phase 2
0.8951 High Similarity NPD7410 Clinical (unspecified phase)
0.8921 High Similarity NPD2796 Approved
0.8904 High Similarity NPD4380 Phase 2
0.8851 High Similarity NPD2393 Clinical (unspecified phase)
0.8849 High Similarity NPD1510 Phase 2
0.8832 High Similarity NPD1240 Approved
0.8792 High Similarity NPD8443 Clinical (unspecified phase)
0.8784 High Similarity NPD6801 Discontinued
0.8716 High Similarity NPD7411 Suspended
0.8705 High Similarity NPD1607 Approved
0.8675 High Similarity NPD7075 Discontinued
0.8601 High Similarity NPD2800 Approved
0.86 High Similarity NPD7096 Clinical (unspecified phase)
0.8571 High Similarity NPD6651 Approved
0.8553 High Similarity NPD4381 Clinical (unspecified phase)
0.8533 High Similarity NPD1934 Approved
0.8531 High Similarity NPD970 Clinical (unspecified phase)
0.8493 Intermediate Similarity NPD6799 Approved
0.8477 Intermediate Similarity NPD7819 Suspended
0.8418 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8387 Intermediate Similarity NPD6959 Discontinued
0.8367 Intermediate Similarity NPD1511 Approved
0.8355 Intermediate Similarity NPD2801 Approved
0.8345 Intermediate Similarity NPD1243 Approved
0.8345 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8311 Intermediate Similarity NPD2534 Approved
0.8311 Intermediate Similarity NPD2533 Approved
0.8311 Intermediate Similarity NPD2532 Approved
0.8288 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.8286 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8278 Intermediate Similarity NPD6599 Discontinued
0.8255 Intermediate Similarity NPD1512 Approved
0.8247 Intermediate Similarity NPD7768 Phase 2
0.8247 Intermediate Similarity NPD3882 Suspended
0.8228 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8228 Intermediate Similarity NPD6166 Phase 2
0.8228 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8228 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.82 Intermediate Similarity NPD920 Approved
0.82 Intermediate Similarity NPD5403 Approved
0.8176 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.8163 Intermediate Similarity NPD3750 Approved
0.8138 Intermediate Similarity NPD1551 Phase 2
0.8125 Intermediate Similarity NPD3818 Discontinued
0.8098 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.8075 Intermediate Similarity NPD7054 Approved
0.8067 Intermediate Similarity NPD5401 Approved
0.8067 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.8065 Intermediate Similarity NPD3817 Phase 2
0.8025 Intermediate Similarity NPD7074 Phase 3
0.8025 Intermediate Similarity NPD7472 Approved
0.8014 Intermediate Similarity NPD2935 Discontinued
0.7986 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7986 Intermediate Similarity NPD5124 Phase 1
0.7975 Intermediate Similarity NPD6797 Phase 2
0.7975 Intermediate Similarity NPD5953 Discontinued
0.7975 Intermediate Similarity NPD5494 Approved
0.7963 Intermediate Similarity NPD7286 Phase 2
0.7945 Intermediate Similarity NPD2799 Discontinued
0.7945 Intermediate Similarity NPD7033 Discontinued
0.7927 Intermediate Similarity NPD7251 Discontinued
0.7927 Intermediate Similarity NPD6559 Discontinued
0.7919 Intermediate Similarity NPD4628 Phase 3
0.7899 Intermediate Similarity NPD422 Phase 1
0.7898 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7879 Intermediate Similarity NPD7808 Phase 3
0.7852 Intermediate Similarity NPD2654 Approved
0.7848 Intermediate Similarity NPD3749 Approved
0.7842 Intermediate Similarity NPD9717 Approved
0.7838 Intermediate Similarity NPD2344 Approved
0.7834 Intermediate Similarity NPD5402 Approved
0.7823 Intermediate Similarity NPD3748 Approved
0.7801 Intermediate Similarity NPD1203 Approved
0.7799 Intermediate Similarity NPD919 Approved
0.7778 Intermediate Similarity NPD2313 Discontinued
0.7778 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.777 Intermediate Similarity NPD6099 Approved
0.777 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.777 Intermediate Similarity NPD6100 Approved
0.7764 Intermediate Similarity NPD6232 Discontinued
0.7762 Intermediate Similarity NPD6832 Phase 2
0.7744 Intermediate Similarity NPD5844 Phase 1
0.7737 Intermediate Similarity NPD1548 Phase 1
0.7733 Intermediate Similarity NPD4363 Phase 3
0.7733 Intermediate Similarity NPD4360 Phase 2
0.773 Intermediate Similarity NPD7473 Discontinued
0.7703 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7702 Intermediate Similarity NPD1247 Approved
0.7682 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7655 Intermediate Similarity NPD3268 Approved
0.7654 Intermediate Similarity NPD5710 Approved
0.7654 Intermediate Similarity NPD5711 Approved
0.7644 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7639 Intermediate Similarity NPD4908 Phase 1
0.7632 Intermediate Similarity NPD2309 Approved
0.7609 Intermediate Similarity NPD9545 Approved
0.759 Intermediate Similarity NPD1729 Discontinued
0.7586 Intermediate Similarity NPD4361 Phase 2
0.7586 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7552 Intermediate Similarity NPD2797 Approved
0.7551 Intermediate Similarity NPD943 Approved
0.7545 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7534 Intermediate Similarity NPD1296 Phase 2
0.7532 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD7390 Discontinued
0.7518 Intermediate Similarity NPD1610 Phase 2
0.7516 Intermediate Similarity NPD3226 Approved
0.75 Intermediate Similarity NPD1241 Discontinued
0.75 Intermediate Similarity NPD230 Phase 1
0.75 Intermediate Similarity NPD2798 Approved
0.7464 Intermediate Similarity NPD9493 Approved
0.7434 Intermediate Similarity NPD2424 Discontinued
0.7415 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD6104 Discontinued
0.7394 Intermediate Similarity NPD3926 Phase 2
0.7386 Intermediate Similarity NPD1652 Phase 2
0.7379 Intermediate Similarity NPD1019 Discontinued
0.7372 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD6004 Phase 3
0.7368 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD2346 Discontinued
0.7368 Intermediate Similarity NPD6005 Phase 3
0.7368 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD6002 Phase 3
0.7361 Intermediate Similarity NPD3225 Approved
0.7351 Intermediate Similarity NPD4308 Phase 3
0.7343 Intermediate Similarity NPD3972 Approved
0.7315 Intermediate Similarity NPD1613 Approved
0.7315 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD3267 Approved
0.731 Intermediate Similarity NPD3266 Approved
0.7305 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD6798 Discontinued
0.7297 Intermediate Similarity NPD411 Approved
0.7296 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD4749 Approved
0.7268 Intermediate Similarity NPD7584 Approved
0.7267 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD447 Suspended
0.7261 Intermediate Similarity NPD4661 Approved
0.7261 Intermediate Similarity NPD4662 Approved
0.7246 Intermediate Similarity NPD2403 Approved
0.723 Intermediate Similarity NPD3027 Phase 3
0.723 Intermediate Similarity NPD4625 Phase 3
0.7222 Intermediate Similarity NPD1465 Phase 2
0.7222 Intermediate Similarity NPD1608 Approved
0.7216 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD5889 Approved
0.7205 Intermediate Similarity NPD5890 Approved
0.72 Intermediate Similarity NPD3142 Approved
0.72 Intermediate Similarity NPD3140 Approved
0.7188 Intermediate Similarity NPD7458 Discontinued
0.7178 Intermediate Similarity NPD4288 Approved
0.717 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7162 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD6844 Discontinued
0.716 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD6355 Discontinued
0.7152 Intermediate Similarity NPD1933 Approved
0.7143 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7127 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD7229 Phase 3
0.7124 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD5761 Phase 2
0.7117 Intermediate Similarity NPD5760 Phase 2
0.711 Intermediate Similarity NPD8312 Approved
0.711 Intermediate Similarity NPD8313 Approved
0.7095 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD7212 Phase 2
0.7089 Intermediate Similarity NPD7213 Phase 3
0.7086 Intermediate Similarity NPD4307 Phase 2
0.7078 Intermediate Similarity NPD4476 Approved
0.7078 Intermediate Similarity NPD4477 Approved
0.7075 Intermediate Similarity NPD1164 Approved
0.7073 Intermediate Similarity NPD2296 Approved
0.707 Intermediate Similarity NPD3887 Approved
0.7067 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7066 Intermediate Similarity NPD7199 Phase 2
0.7059 Intermediate Similarity NPD3751 Discontinued
0.7055 Intermediate Similarity NPD37 Approved
0.7047 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD6585 Discontinued
0.7034 Intermediate Similarity NPD1091 Approved
0.7034 Intermediate Similarity NPD1201 Approved
0.7032 Intermediate Similarity NPD1471 Phase 3
0.703 Intermediate Similarity NPD4965 Approved
0.703 Intermediate Similarity NPD4966 Approved
0.703 Intermediate Similarity NPD4967 Phase 2
0.7027 Intermediate Similarity NPD5647 Approved
0.7024 Intermediate Similarity NPD3787 Discontinued
0.702 Intermediate Similarity NPD6233 Phase 2
0.7019 Intermediate Similarity NPD1653 Approved
0.7014 Intermediate Similarity NPD1778 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data